A detailed history of Pale Fire Capital Se transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 37,375 shares of IOVA stock, worth $223,876. This represents 0.06% of its overall portfolio holdings.

Number of Shares
37,375
Previous 14,700 154.25%
Holding current value
$223,876
Previous $118 Million 197.68%
% of portfolio
0.06%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.28 - $11.9 $165,074 - $269,832
22,675 Added 154.25%
37,375 $351 Million
Q2 2024

Aug 13, 2024

BUY
$7.78 - $14.19 $28,786 - $52,503
3,700 Added 33.64%
14,700 $118 Million
Q1 2024

May 14, 2024

SELL
$7.59 - $17.47 $45,722 - $105,239
-6,024 Reduced 35.39%
11,000 $163 Million
Q4 2023

Feb 13, 2024

BUY
$3.3 - $8.89 $6,349 - $17,104
1,924 Added 12.74%
17,024 $138 Million
Q3 2023

Nov 13, 2023

BUY
$4.44 - $8.79 $67,044 - $132,729
15,100 New
15,100 $68.7 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $945M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.